Search results for: 'post post analysis for laboratory develop'

Increasing population and low fresh water availability are the major reasons driving the UAE water and wastewater sector. With a huge focus on economic diversification, investments in real estate are high, which will lead to an increasing demand for water in the future, thereby creating opportunities for treated sewage and desalination. Increase in...

29 Oct 2021  |  North America  |  Market Research

US Commercial Unmanned Aerial Systems (UAS) Growth Opportunities

Strategic Partnering and New Product Development to Propel Growth

Infographics

×

This Frost & Sullivan research service focuses on the US commercial unmanned aerial system (UAS) market. The base year for spending information is 2020, and example market participants and market size estimates for 2021 are provided. This study discusses market participants, customers, and government agencies that influence the industry. The v...

Lubricants are typically employed to reduce friction between interacting components, serving a crucial function in preventing equipment malfunctions and operational disruptions across diverse industries. From 2020 to 2023, global lubricant consumption registered slow growth. Owing to restrictions during the COVID-19 pandemic, many industries observ...

The rapid adoption of cloud computing, microservices, and AI has drastically increased the number of machine identities and secrets that organizations must manage. These secrets are fundamental to enabling secure authentication and authorization between workloads, applications, and third-party services operating across a wide range of environments,...

27 Feb 2025  |  Global  |  

Wind Turbine Materials Market, Global, 2024-2031

Rising Focus on Improving Product Technologies and Developing New Alternatives is Driving Transformational Growth

Infographics

×

Frost & Sullivan divided the wind turbine materials market into structural and non-structural materials. We further classified the structural materials market into metals, fiber-reinforced composites, and core materials, while the non-structural materials market contains coatings, adhesives and sealants, and lubricants. Each material has been segme...

The APAC network security market witnessed a slower YoY growth of 7.8% in Q3, 2021, when compared to the double-digit YoY growth of 16.7% the previous quarter; this indicates a steady post-crisis recovery and shift out of the market’s strong rebound phase. The firewall segment remained the biggest technology segment driving the overall network secu...

Cities are evolving toward a more sustainable and efficient model. A focus area is reducing carbon emissions by adopting renewable energy sources like solar and wind power and promoting electric vehicles. In addition, there is a shift toward pedestrian-friendly urban design, with wider sidewalks, bike lanes, and increased green spaces. Cities want ...

20 Nov 2017  |  North America  |  Market Research

Global Biologics Market—Companies-to-Action

Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

Infographics

×

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...